ImmunoGen Inc. (IMGN)
NASDAQ: IMGN
· Real-Time Price · USD
31.23
0.00 (0.00%)
At close: Feb 09, 2024, 9:58 PM
ImmunoGen Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 605.53M | 571.99M | 201.25M | 275.14M | 309.51M | 373.87M | 437.66M | 478.75M | 245.76M | 239.54M | 283.12M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 68.64M | 129.57M | 73.4M | 59.19M | 13.1M | 32.73M | 8.67M | 29.96M | 33.66M | 43.74M | 43.78M |
Receivables | 130.69M | 79.96M | 31.05M | 17.98M | 4.19M | 5.95M | 10.25M | 13.93M | 10.8M | 20.36M | 21.03M |
Inventory | 5.5M | 3.23M | 614K | 16.2M | n/a | -20.05M | n/a | -21.25M | -25.13M | -34.86M | -36.45M |
Other Current Assets | 22.15M | 14.09M | 10.96M | 11.01M | 16.71M | 14.1M | 8.81M | 7.32M | 14.33M | 14.5M | 15.42M |
Total Current Assets | 736.23M | 571.99M | 201.25M | 275.14M | 330.42M | 373.87M | 456.72M | 478.75M | 245.76M | 239.54M | 283.12M |
Property-Plant & Equipment | 17.23M | 12.77M | 13.69M | 14.61M | 15.28M | 15.7M | 16.32M | 17.05M | 17.38M | 18.16M | 19.07M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 85.87M | 142.34M | 87.1M | 73.8M | 28.38M | 48.42M | 24.99M | 47.02M | 51.04M | 61.91M | 62.84M |
Total Assets | 822.1M | 714.33M | 288.35M | 348.94M | 358.8M | 422.3M | 481.71M | 525.76M | 296.8M | 301.45M | 345.96M |
Account Payables | 24.85M | 18.44M | 32.26M | 45.35M | 20.18M | 17.25M | 16.06M | 18.43M | 10.52M | 11.63M | 12.92M |
Deferred Revenue | 37.19M | 14.39M | 13.44M | 13.86M | 15.08M | 15.64M | 23.42M | 44.35M | 53.53M | 53.79M | 51.52M |
Short-Term Debt | -24.85M | 4.33M | 4.21M | 4.1M | 3.98M | 3.87M | 3.76M | 3.54M | 3.36M | 4.3M | 5.21M |
Other Current Liabilities | 97.47M | 56.54M | 51.71M | 58.55M | 64.4M | 50.32M | 40.88M | 34.62M | 44.38M | 50.6M | 64.71M |
Total Current Liabilities | 134.66M | 93.7M | 101.63M | 121.86M | 103.64M | 87.07M | 84.12M | 100.94M | 111.78M | 120.32M | 134.35M |
Long-Term Debt | 72.11M | 71.96M | 10.05M | 11.15M | 12.22M | 13.25M | 14.26M | 15.24M | 16.05M | 16.97M | 17.88M |
Other Long-Term Liabilities | 27.01M | 27.61M | 20.69M | 23.75M | 26.2M | 28.53M | 30.17M | 51.52M | 55.45M | 57.18M | 58.97M |
Total Long-Term Liabilities | 125.84M | 129.78M | 64.8M | 71.25M | 77.15M | 85.39M | 91.12M | 99.23M | 107.92M | 112.66M | 117.49M |
Total Liabilities | 260.5M | 223.49M | 166.43M | 193.11M | 180.79M | 172.46M | 175.24M | 200.18M | 219.71M | 232.98M | 251.84M |
Total Debt | 72.11M | 71.96M | 14.26M | 15.24M | 16.2M | 17.12M | 18.02M | 18.78M | 19.4M | 21.27M | 23.09M |
Common Stock | 2.44M | 2.37M | 2.26M | 2.26M | 2.21M | 2.21M | 2.21M | 2.2M | 2.02M | 2M | 2M |
Retained Earnings | -1.71B | -1.74B | -1.74B | -1.69B | -1.64B | -1.56B | -1.5B | -1.47B | -1.43B | -1.4B | -1.37B |
Comprehensive Income | 2.27B | 2.23B | 1.86B | 1.85B | 1.81B | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 561.6M | 490.84M | 121.92M | 155.83M | 178.01M | 249.83M | 306.47M | 325.59M | 77.09M | 68.47M | 94.12M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |